Coyle, Joseph T.

Oxidative Stress, Glutamate, and Neurodegenerative Disorders

Coyle, J. T., & Puttfarcken, P. (1993) · Science

Neuroscience and Neuropharmacology ResearchRedox biology and oxidative stress

Cited by 3,762

Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis

Whitehouse, P. J., Price, D. L., Clark, A. W., Coyle, J. T., & DeLong, M. R. (1981) · Annals of Neurology

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 1,736

Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia

Lisman, J. E., Coyle, J. T., Green, R. W., Javitt, D. C., Benes, F. M., Heckers, S., & Grace, A. A. (2008) · Trends in Neurosciences

Schizophrenia research and treatmentNeuroscience and Neuropharmacology Research

Cited by 1,010

Glutamate and Schizophrenia: Beyond the Dopamine Hypothesis

Coyle, J. T. (2006) · Cellular and Molecular Neurobiology

Schizophrenia research and treatmentNeuroscience and Neuropharmacology Research

Cited by 917

Glutamatergic mechanisms in schizophrenia

Tsai, G., & Coyle, J. T. (2002) · Annual Review of Pharmacology and Toxicology

Schizophrenia research and treatmentNeuroscience and Neuropharmacology Research

Cited by 577

The Glutamatergic Dysfunction Hypothesis for Schizophrenia

Coyle, J. T. (1996) · Harvard Review of Psychiatry

Schizophrenia research and treatmentNeuroscience and Neuropharmacology Research

Cited by 568

Oxidative stress-driven parvalbumin interneuron impairment as a common mechanism in models of schizophrenia

Steullet, P., Cabungcal, J.-H., Coyle, J., Didriksen, M., Gill, K., Grace, A. A., Hensch, T. K., LaMantia, A.-S., Lindemann, L., Maynard, T. M., et al. (2017) · Molecular Psychiatry

Schizophrenia research and treatmentNeuroscience and Neuropharmacology Research

Cited by 360

The neurobiologie consequences of down syndrome

Coyle, J. T., Oster-Granite, M. L., & Gearhart, J. D. (1986) · Brain Research Bulletin

Down syndrome and intellectual disability researchAlzheimer's disease research and treatments

Cited by 248

Multiple risk pathways for schizophrenia converge in serine racemase knockout mice, a mouse model of NMDA receptor hypofunction

Balu, D. T., Li, Y., Puhl, M. D., Benneyworth, M. A., Basu, A. C., Takagi, S., Bolshakov, V. Y., & Coyle, J. T. (2013) · Proceedings of the National Academy of Sciences

Schizophrenia research and treatmentAmino Acid Enzymes and Metabolism

Cited by 217

The NMDA receptor ‘glycine modulatory site’ in schizophrenia: d-serine, glycine, and beyond

Balu, D. T., & Coyle, J. T. (2015) · Current Opinion in Pharmacology

Schizophrenia research and treatmentAmino Acid Enzymes and Metabolism

Cited by 208

Dopaminergic dysfunction in tourette syndrome

Singer, H. S., Butler, I. J., Tune, L. E., Seifert, W. E., & Coyle, J. T. (1982) · Annals of Neurology

Obsessive-Compulsive Spectrum DisordersNeurotransmitter Receptor Influence on Behavior

Cited by 180

Glutamatergic Synaptic Dysregulation in Schizophrenia: Therapeutic Implications

Coyle, J. T., Basu, A., Benneyworth, M., Balu, D., & Konopaske, G. (2012) · Handbook of Experimental Pharmacology

Schizophrenia research and treatmentNeuroscience and Neuropharmacology Research

Cited by 180

Evidence for a hippocampal-septal glutamatergic pathway in the rat

Zaczek, R., Hedreen, J. C., & Coyle, J. T. (1979) · Experimental Neurology

Neuroscience and Neuropharmacology ResearchMemory and Neural Mechanisms

Cited by 95

Identity of endogenous NMDAR glycine site agonist in amygdala is determined by synaptic activity level

Li, Y., Sacchi, S., Pollegioni, L., Basu, A. C., Coyle, J. T., & Bolshakov, V. Y. (2013) · Nature Communications

Neuroscience and Neuropharmacology ResearchMemory and Neural Mechanisms

Cited by 82